Cyclodextrin protects podocytes in diabetic kidney disease [HumanHT-12 V4.0 array]
Source: NCBI BioProject (ID PRJNA202985)
Source: NCBI BioProject (ID PRJNA202985)
0 0
Project name: Homo sapiens
Description: Analysis of gene expression changes in differentiated human podocytes treated with the serum from patients with (DKD+) or without (DKD-) diabetic kidney disease when compared to normal subjects (C). The hypothesis is that the three groups can be distinghed by their differentialgene expression pattern. The results obtained revealed important information regarding differences in gene expression in human podocytes treated with the serum from patients with (DKD+) or without (DKD-) diabetic kidney disease when compared to normal subjects (C).Overall design: Human podocytes were contacted with the serum from patients with diabetes and kidney disease (DKD+) or without kidney disease (DKD-) and compared to normal human podocytes contacted with serum from patients without diabetes (C).
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: Medicine, University of Miami
Literatures
- PMID: 23835338
Last updated: 2013-05-14